VP Head of Development for Ex Vivo Programs


Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together. How you will Achieve More with Intellia: We are hiring a Head of Development for WT-1 and Ex Vivo Programs to act as program team leader for WT-1 and to oversee all functions for the ex vivo programs, including clinical, regulatory, and biometrics.  You will be responsible for the development and execution of short and long-term medical plans supporting ex vivo cell therapy programs in both immuno-oncology and autoimmunity, and aligning them with overall business goals.  A significant portion of time will be externally-facing and the Head of Development Ex Vivo will provide therapeutic area/product expertise in oncological and autoimmune indications and understand both the patient’s and physician’s point of view.  Working with cross-functional colleagues, you will ensure that the clinical development plan is in line with the brand strategies and helps support successful product development, medical launch, and commercialization. Lead the development and execution of the ex vivo programs, including medical and registrational strategies and tactics for assigned clinical research projects Head up the development team starting at the time of CTA/IND or proof of concept depending on the program, including all functions: clinical, regulatory, biostatistics, program management, clinical operations, tech ops/CMC, clinical pharmacology, research, and preclinical development, to design and execute clinical development plans for assigned projects Support activities related to safety evaluations and reporting requirements About You: We are looking for candidates with a Doctoral degree (M.D) or foreign equivalent, with or without a Ph.D. with 12 years or more experience in drug development roles in a pharmaceutical industrial R&D setting. Additional role requirements include: Served as clinical and, ideally, project leader during multiple phases of drug development Participated in key regulatory interactions with the FDA, EMA, or similar national agencies Knowledge and experience in gene therapy and/or oncology and autoimmunity is preferred Strong analytic skills Professional demeanor & excellent interpersonal skills when dealing with external customers / internal colleagues Meet your future team: The Clinical Development team at Intellia is made up of one or more people in functions related to clinical research, including but not limited to biometrics, clinical operations, clinical pharmacology, medical science, medical writing, project leadership, project management, and regulatory affairs.  We are here because we believe genome editing has incredible potential to treat and cure life-threatening and fatal diseases, and we believe that Intellia has the right people, strategy, and culture to do it well. The team is led by our CMO, a physician and medical oncologist with over 25 years of experience in large pharma and biotech drug development.  Other senior team members have 10 or years of similar experience, including many with prior direct experience in nucleic acid therapeutics and cell therapy.  Your medical colleagues at Intellia are physicians/scientists who share responsibility across the three development-stage programs as Project Leads and Medical Leads. Their responsibility will increase in the coming years as Intellia’s pipeline moves further into clinical development. #LI-KD1 Covid-19 Vaccination Policy: Effective Monday, January 3, 2022, all Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. Requests for exemption for medical or sincerely held religious beliefs will be considered. EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.